The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Next-generation sequencing (NGS) of tissue and cell free DNA (cfDNA) to identify somatic and germline alterations in advanced prostate cancer.
 
Michael L. Cheng
No Relationships to Disclose
 
Wassim Abida
Honoraria - CARET
Consulting or Advisory Role - Clovis Oncology
Research Funding - AstraZeneca; Zenith Epigenetics
 
Dana E. Rathkopf
Consulting or Advisory Role - Janssen Oncology
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Maria E. Arcila
No Relationships to Disclose
 
David Barron
No Relationships to Disclose
 
Karen A. Autio
No Relationships to Disclose
 
Ahmet Zehir
No Relationships to Disclose
 
Daniel Costin Danila
Honoraria - Angle; Astellas Scientific and Medical Affairs Inc; Bayer; Xian-Janssen Pharmaceutical
Consulting or Advisory Role - Angle; Bayer
Research Funding - Genentech; Janssen Research & Development (Inst); Prostate Cancer Foundation
Patents, Royalties, Other Intellectual Property - GENE EXPRESSION PROFILE ASSOCIATED WITH PROSTATE CANCER
Travel, Accommodations, Expenses - American Austrian Open Medical Institute; Angle; Bayer; Cambridge Healthtech Institute; Global Technology Community; Oncology Education; Prostate Cancer Foundation; Xian-Janssen Pharmaceutical
 
Michael J. Morris
Consulting or Advisory Role - Astellas Pharma; Bayer; Endocyte
Research Funding - Bayer (Inst); Endocyte (Inst); Progenics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Endocyte
 
Anuradha Gopalan
No Relationships to Disclose
 
Victor E. Reuter
No Relationships to Disclose
 
Philip W. Kantoff
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; Druggablity Technologies; Metamark Genetics; Placon; Tarveda Therapeutics
Consulting or Advisory Role - Astellas Pharma; Bavarian Nordic; Bayer; Bellicum Pharmaceuticals; BIND Biosciences; Cristal Therapeutics; Druggablity Technologies; Endocyte; Genentech/Roche; GTx; Ipsen; Janssen; Medivation; Merck; Metamark Genetics; Millennium; MorphoSys; MorphoSys; MTG Therapeutics; Omnitura; OncoCellMDX; Oncogenex; Pfizer; Progenity; Sanofi; Sotio; Tarveda Therapeutics; Tokai Pharmaceuticals
Research Funding - Amgen (Inst); Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Bayer (Inst); Dendreon (Inst); Exelixis (Inst); Janssen (Inst); Medivation (Inst); Oncogenex (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Chromosome Copy Number Gain as a Biomarker of Urothelial Carcinoma Lethality; Drug Combinations to Treat Cancer; Method for Predicting the Risk of Prostate Cancer Morbidity and Mortality; Methods for Predicting Likelihood of Responding to Treatment; Predicting and Treating Prostate Cancer; Somatic ERCC2 Mutations Correlate with Cisplatin sensitivity in muscle-invasive Urothelial Carcinoma (Patent); Up-to-Date Royalties; Wolters Kluwer Royalties
Expert Testimony - Janssen; Sanofi
Travel, Accommodations, Expenses - Bavarian Nordic; BIND Biosciences; Janssen; Millennium; Sanofi
 
Susan F. Slovin
Consulting or Advisory Role - Bayer
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; McKesson
Research Funding - AbbVie (Inst); AstraZeneca (Inst); Biomarin (Inst); Medivation (Inst); Myriad Genetics (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Liying Zhang
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Dana Tsui
No Relationships to Disclose
 
Barry S. Taylor
No Relationships to Disclose
 
David B. Solit
Honoraria - Loxo; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Howard I. Scher
Leadership - Asterias Biotherapeutics
Consulting or Advisory Role - Astellas Pharma; Blue Earth Diagnostics; Clovis Oncology; Elsevier; Ferring; Janssen Research & Development; Med IQ; Medivation; Merck; Roche; Sanofi; WIRB-Copernicus Group
Research Funding - Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ferring; Medivation; Roche; WIRB-Copernicus Group